4-nitro-1H-pyrazol-3-amine
|
N682366-250mg
|
≥97% |
16115-82-5 |
250mg
|
¥ 1952.9
|
期货,请咨询 |
阿拉丁 |
4-nitro-1H-pyrazol-3-amine
|
N682366-1g
|
≥97% |
16115-82-5 |
1g
|
¥ 3280.9
|
期货,请咨询 |
阿拉丁 |
4-nitro-1H-pyrazol-3-amine
|
N682366-10g
|
≥97% |
16115-82-5 |
10g
|
¥ 20288.9
|
期货,请咨询 |
阿拉丁 |
4-nitro-1H-pyrazol-3-amine
|
N682366-100mg
|
≥97% |
16115-82-5 |
100mg
|
¥ 1520.9
|
期货,请咨询 |
阿拉丁 |
[(5S,9S)-1-azaspiro[4.4]nonan-9-yl] acetate
|
N682341-5g
|
≥97% |
1787263-48-2 |
5g
|
¥ 43200.9
|
期货,请咨询 |
阿拉丁 |
[(5S,9S)-1-azaspiro[4.4]nonan-9-yl] acetate
|
N682341-500mg
|
≥97% |
1787263-48-2 |
500mg
|
¥ 10080.9
|
期货,请咨询 |
阿拉丁 |
[(5S,9S)-1-azaspiro[4.4]nonan-9-yl] acetate
|
N682341-250mg
|
≥97% |
1787263-48-2 |
250mg
|
¥ 7056.9
|
期货,请咨询 |
阿拉丁 |
[(5S,9S)-1-azaspiro[4.4]nonan-9-yl] acetate
|
N682341-1g
|
≥97% |
1787263-48-2 |
1g
|
¥ 14400.9
|
期货,请咨询 |
阿拉丁 |
[(5S,9S)-1-azaspiro[4.4]nonan-9-yl] acetate
|
N682341-10g
|
≥97% |
1787263-48-2 |
10g
|
¥ 72000.9
|
期货,请咨询 |
阿拉丁 |
[(5S,9S)-1-azaspiro[4.4]nonan-9-yl] acetate
|
N682341-100mg
|
≥97% |
1787263-48-2 |
100mg
|
¥ 4240.9
|
期货,请咨询 |
阿拉丁 |
N,N,3,4-tetramethyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazole-1-sulfonamide
|
N682267-5g
|
≥97% |
N/A |
5g
|
¥ 24000.9
|
期货,请咨询 |
阿拉丁 |
N,N,3,4-tetramethyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazole-1-sulfonamide
|
N682267-500mg
|
≥97% |
N/A |
500mg
|
¥ 5328.9
|
期货,请咨询 |
阿拉丁 |
N,N,3,4-tetramethyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazole-1-sulfonamide
|
N682267-250mg
|
≥97% |
N/A |
250mg
|
¥ 3200.9
|
期货,请咨询 |
阿拉丁 |
N,N,3,4-tetramethyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazole-1-sulfonamide
|
N682267-1g
|
≥97% |
N/A |
1g
|
¥ 8000.9
|
期货,请咨询 |
阿拉丁 |
N,N,3,4-tetramethyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazole-1-sulfonamide
|
N682267-10g
|
≥97% |
N/A |
10g
|
¥ 40000.9
|
期货,请咨询 |
阿拉丁 |
N,N,3,4-tetramethyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazole-1-sulfonamide
|
N682267-100mg
|
≥97% |
N/A |
100mg
|
¥ 1920.9
|
期货,请咨询 |
阿拉丁 |
[(1R,2R,4S)-6-azatricyclo[4.3.0.0²⁴]nonan-1-yl]methanol
|
N682262-5g
|
≥97% |
N/A |
5g
|
¥ 38400.9
|
期货,请咨询 |
阿拉丁 |
[(1R,2R,4S)-6-azatricyclo[4.3.0.0²⁴]nonan-1-yl]methanol
|
N682262-500mg
|
≥97% |
N/A |
500mg
|
¥ 8528.9
|
期货,请咨询 |
阿拉丁 |
[(1R,2R,4S)-6-azatricyclo[4.3.0.0²⁴]nonan-1-yl]methanol
|
N682262-250mg
|
≥97% |
N/A |
250mg
|
¥ 5120.9
|
期货,请咨询 |
阿拉丁 |
[(1R,2R,4S)-6-azatricyclo[4.3.0.0²⁴]nonan-1-yl]methanol
|
N682262-1g
|
≥97% |
N/A |
1g
|
¥ 12800.9
|
期货,请咨询 |
阿拉丁 |
[(1R,2R,4S)-6-azatricyclo[4.3.0.0²⁴]nonan-1-yl]methanol
|
N682262-10g
|
≥97% |
N/A |
10g
|
¥ 64000.9
|
期货,请咨询 |
阿拉丁 |
[(1R,2R,4S)-6-azatricyclo[4.3.0.0²⁴]nonan-1-yl]methanol
|
N682262-100mg
|
≥97% |
N/A |
100mg
|
¥ 3072.9
|
期货,请咨询 |
阿拉丁 |
[rel-(1S,2S,4R)-6-azatricyclo[4.3.0.0²⁴]nonan-1-yl]methanol
|
N682261-5g
|
≥97% |
2956676-50-7 |
5g
|
¥ 38400.9
|
期货,请咨询 |
阿拉丁 |
[rel-(1S,2S,4R)-6-azatricyclo[4.3.0.0²⁴]nonan-1-yl]methanol
|
N682261-500mg
|
≥97% |
2956676-50-7 |
500mg
|
¥ 8528.9
|
期货,请咨询 |
阿拉丁 |